Inflammatory profile in cerebrospinal fluid of patients with headache as a manifestation of neuropsychiatric systemic lupus erythematosus

Rheumatology (United Kingdom)

Volumn 52, Issue 12, 2013, Pages 2218-2222

  Fragoso Loyo, Hilda ^a   Atisha Fregoso, Yemil ^a   Llorente, Luis ^a   Sánchez Guerrero, Jorge ^a,b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Cerebrospinal fluid; Chemokines; CNS; Cytokines; Headache; IL 6; Intracranial hypertension; Intractable non specific headache; Neuropsychiatric systemic lupus erythematosus; SLE

Indexed keywords

ALPHA INTERFERON; CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HEADACHE; HUMAN; INTRACRANIAL HYPERTENSION; MALE; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; POST HOC ANALYSIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

CEREBROSPINAL FLUID; CHEMOKINES; CNS; CYTOKINES; HEADACHE; IL-6; INTRACRANIAL HYPERTENSION; INTRACTABLE NON-SPECIFIC HEADACHE; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; SLE;

ADULT; CASE-CONTROL STUDIES; CHEMOKINES; CHRONIC DISEASE; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HEADACHE DISORDERS; HOSPITALIZATION; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE;

EID: 84887769178     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket294     Document Type: Article

References (18)

1. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
2. Hanly JG, McCurdy G, Fougere L et al. Neuropsychiatric events in systemic lupus erythematosus:attribution and clinical significance. J Rheumatol 2004;31:2156-62.
3. Hanly JG, Urowitz MB, Sanchez-Guerrero J et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus:an international inception cohort study. Arthritis Rheum 2007;56:265-73.
4. Ainiala H, Hietaharju A, Loukkola J et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes:a population-based evaluation. Arthritis Rheum 2001;45:419-23.
5. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29:288-91.
6. Isenberg DA, Rahman A, Allen E et al. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology 2005;44:902-6.
7. Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narváez A et al. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 2007;56:1242-50.
8. Fragoso-Loyo H, Cabiedes J, Orozco-Narvaez A et al. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS One 2008;3:e3347.
9. Fragoso-Loyo H, Cabiedes J, Richaud-Patin Y et al. Inflammatory profile in the cerebrospinal fluid of patients with central neuropsychiatric lupus, with and without associated factors. Rheumatology 2009;48:1615-6.
10. Fragoso-Loyo H, Cabiedes J, Atisha-Fregoso Y et al. Utility of serum S100B protein for the identification of central nervous system involvement in systemic lupus erythematosus. J Rheumatol 2010;37:2280-5.
11. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
12. Gladman DD, Ginzler E, Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
13. Alcocer-Varela J, Aleman-Hoey D, Alarcon-Segovia D. Interleukin-1 and interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers. Lupus 1992;1:111-7.
14. Trysberg E, Carlsten H, Tarkowski A. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus 2000;9:498-503.
15. Ikuni N, Okamoto H, Yoshio T et al. Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus. Ann Rheum Dis 2006;65:253-6.
16. Okamoto H, Katsumata Y, Nishimura K et al. Interferoninducible protein 10/CXCL10 is increased in the cerebrospinal fluid of patients with central nervous system. Arthritis Rheum 2004;50:3731-2.
17. Okamoto H, Kobayashi A, Yamanaka H. Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus. J Biomed Biotechnol 2010;2010:268436.
18. Bø SH, Davidsen EM, Gulbrandsen P et al. Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia 2009;29:365-72.